LAVA Therapeutics (LVTX) Short Interest Ratio & Short Volume → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free LVTX Stock Alerts $3.11 +0.03 (+0.97%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media LAVA Therapeutics Short Interest DataCurrent Short Volume193,800 sharesPrevious Short Volume211,600 sharesChange Vs. Previous Month-8.41%Dollar Volume Sold Short$567,834.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Float Size14,120,000 sharesShort Percent of Float1.37%Today's Trading Volume108,822 sharesAverage Trading Volume1,296,559 sharesToday's Volume Vs. Average8% Short Selling LAVA Therapeutics ? Sign up to receive the latest short interest report for LAVA Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatLVTX Short Interest Over TimeLVTX Days to Cover Over TimeLVTX Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide LAVA Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024193,800 shares $567,834.00 -8.4%1.4%0.1 $2.93 3/31/2024211,600 shares $704,628.00 -34.3%1.5%0.1 $3.33 3/15/2024322,100 shares $950,195.00 +476.2%2.3%0.2 $2.95 2/29/202455,900 shares $186,147.00 +448.0%0.5%0 $3.33 2/15/202410,200 shares $20,604.00 -88.4%0.1%0 $2.02 1/31/202487,700 shares $146,459.00 +853.3%0.7%0.1 $1.67 Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20249,200 shares $15,364.00 +15.0%0.1%0.3 $1.67 12/31/20238,000 shares $12,640.00 -27.3%0.1%0.2 $1.58 12/15/202311,000 shares $17,160.00 -9.8%0.1%0.4 $1.56 11/30/202312,200 shares $18,492.76 -28.7%0.1%0.4 $1.52 11/15/202317,100 shares $25,480.71 -21.6%0.1%0.6 $1.49 10/31/202321,800 shares $25,942.00 -25.3%0.2%0.7 $1.19 10/15/202329,200 shares $40,588.00 -20.4%0.3%1.4 $1.39 9/30/202336,700 shares $53,949.00 -3.2%0.3%1.4 $1.47 9/15/202337,900 shares $64,759.73 -15.0%0.3%1.1 $1.71 8/31/202344,600 shares $78,942.00 +34.7%0.4%0.7 $1.77 8/15/202333,100 shares $59,580.00 -32.0%0.3%0.1 $1.80 7/31/202348,700 shares $91,556.00 -45.2%0.4%0.1 $1.88 7/15/202388,900 shares $176,022.00 +95.4%0.8%0.1 $1.98 6/30/202345,500 shares $92,365.00 -50.7%0.5%0.1 $2.03 6/15/202392,300 shares $180,908.00 +709.7%0.9%0.1 $1.96 5/31/202311,400 shares $21,660.00 -46.2%0.1%0 $1.90 5/15/202321,200 shares $40,280.00 +50.4%0.2%0.4 $1.90 4/30/202314,100 shares $21,291.00 +95.8%0.2%0.2 $1.51 4/15/20237,200 shares $12,816.00 -30.1%0.1%0.1 $1.78 3/31/202310,300 shares $17,098.00 -40.1%0.1%0.2 $1.66 3/15/202317,200 shares $29,584.00 +177.4%0.2%0.3 $1.72 2/28/20236,200 shares $13,888.00 +40.9%0.1%0.1 $2.24 2/15/20234,400 shares $14,872.00 -17.0%0.0%0.1 $3.38 1/31/20235,300 shares $19,292.00 +35.9%0.0%0.2 $3.64 1/15/20233,900 shares $15,015.00 -38.1%0.0%0.1 $3.85 12/30/20226,300 shares $22,050.00 +34.0%0.0%0.1 $3.50 12/15/20224,700 shares $18,142.00 -78.3%0.0%0 $3.86 11/30/202221,700 shares $119,567.00 +130.9%0.1%0 $5.51 11/15/20229,400 shares $50,196.00 No Change0.0%0 $5.34 10/31/20229,400 shares $40,702.00 +213.3%0.0%0 $4.33 10/15/20223,000 shares $11,880.00 -98.1%0.0%0 $3.96 9/30/2022158,800 shares $725,716.00 +14,336.4%1.7%0.2 $4.57 9/15/20221,100 shares $2,574.00 -31.3%0.0%0 $2.34 8/31/20221,600 shares $4,080.00 -36.0%0.0%0.3 $2.55The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide LVTX Short Interest - Frequently Asked Questions What is LAVA Therapeutics' current short interest? Short interest is the volume of LAVA Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 193,800 shares of LVTX short. 1.37% of LAVA Therapeutics' shares are currently sold short. Learn More on LAVA Therapeutics' current short interest. What is a good short interest percentage for LAVA Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.37% of LAVA Therapeutics' floating shares are currently sold short. Is LAVA Therapeutics' short interest increasing or decreasing? LAVA Therapeutics saw a drop in short interest in April. As of April 15th, there was short interest totaling 193,800 shares, a drop of 8.4% from the previous total of 211,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LAVA Therapeutics' float size? LAVA Therapeutics currently has issued a total of 0 shares. Some of LAVA Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LAVA Therapeutics currently has a public float of 14,120,000 shares. How does LAVA Therapeutics' short interest compare to its competitors? 1.37% of LAVA Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to LAVA Therapeutics: Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), Mainz Biomed (2.30%), NLS Pharmaceutics Ltd. (0.34%), Pharvaris (0.87%), American Oncology Network, Inc. (0.83%), Centogene (0.05%), Concord Medical Services Holdings Limited (0.03%), Shattuck Labs, Inc. (4.42%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short LAVA Therapeutics stock? Short selling LVTX is an investing strategy that aims to generate trading profit from LAVA Therapeutics as its price is falling. LVTX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LAVA Therapeutics? A short squeeze for LAVA Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LVTX, which in turn drives the price of the stock up even further. How often is LAVA Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LVTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Context Therapeutics Short Interest Grifols Short Interest Mainz Biomed Short Interest NLS Pharmaceutics Short Interest Pharvaris Short Interest Tiziana Life Sciences Short Interest 180 Life Sciences Short Interest Aclarion Short Interest Ainos Short Interest Alpha Tau Medical Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LVTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersUrgent Nvidia WarningAltimetryObama’s Forever Term [exposed]Porter & Company